| Analysis | Metabolite Name | Measured Value | Units | source | type |
|---|---|---|---|---|---|
| GC-MS | Uracil | 31.9 | relative concentration/10mg DW | mutant | VISA4 |
| GC-MS | Uracil | 35.2 | relative concentration/10mg DW | mutant | VISA4 |
| GC-MS | Uracil | 51.7 | relative concentration/10mg DW | mutant | VISA4 |
| GC-MS | Uracil | 94.1 | relative concentration/10mg DW | mutant | VISA2 |
| GC-MS | Uracil | 103.7 | relative concentration/10mg DW | mutant | VISA2 |
| GC-MS | Uracil | 130.8 | relative concentration/10mg DW | parent | hVISA |
| GC-MS | Uracil | 142.9 | relative concentration/10mg DW | mutant | VISA2 |
| GC-MS | Uracil | 149.9 | relative concentration/10mg DW | mutant | VISA3 |
| GC-MS | Uracil | 163.6 | relative concentration/10mg DW | mutant | VISA3 |
| GC-MS | Uracil | 165.4 | relative concentration/10mg DW | parent | hVISA |
| GC-MS | Uracil | 165.6 | relative concentration/10mg DW | parent | hVISA |
| GC-MS | Uracil | 182.1 | relative concentration/10mg DW | mutant | VISA3 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|